Press Releases

May 20, 2003 HEMISPHERX ANNOUNCES FIRST QUARTER RESULTS

May 19, 2003 Hemispherx Reports Positive Independent Study Results of Alferon N in the Treatment of Pig Coronavirus (Animal Model of SARS)

May 13, 2003 Hemispherx Initiates Collaboration on SARS with Genome Institute of Singapore

May 08, 2003 Hemispherx Biopharma: New NIH Sponsored Data on Ampligen presented with West Nile Virus

May 05, 2003 HEMISPHERX BIOPHARMA ENTERS INTO THERAPEUTIC AGREEMENT FOR AMPLIGEN® WITH THE CENTER FOR CELL AND GENE THERAPY AT BAYLOR COLLEGE OF MEDICINE

Apr 29, 2003 HEMISPHERX REPORTS EXPANDED HIV DATA ON AMPLIGEN AT THE 16th INTERNATIONAL CONFERENCE ON ANTIVIRAL RESEARCH

Apr 22, 2003 HEMISPHERX BIOPHARMA EXTENDS DISTRIBUTOR AGREEMENT FOR ALFERON N Injection

Apr 15, 2003 Hemispherx Biopharma Announces Fourth Quarter and Year 2002 Results

Apr 08, 2003 Webcast Alert: Hemispherx BioPharma, Inc. Announces HEB Presentation at Redchip Partners New York Investor Conference 2003 Webcast

Mar 26, 2003 HEMISPHERX BIOPHARMA APPOINTS DAVID FEDORCZYK DIRECTOR OF CLINICAL AND STATISTICAL AFFAIRS

64 65 66 67 68 69 70 71 72 73 74

<< < > >>